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diagnostic dilemma: a case series
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Abstract
Background: Allergic reactions to amoxicillin are very common occurrences in the pediatric age group; however,
onset of symptoms can present a diagnostic dilemma.
Case presentation: We present a case series that describes three children (8-year-old white girl, 2-year-old white
boy and 14-month-old Chinese boy) who presented with varied onset of allergic reactions to amoxicillin, specifically
immediate (within the first hour after exposure) and non-immediate onset. One child developed immediate onset
allergy to oral challenge with amoxicillin although his clinical history was evident for non-immediate onset allergy
to amoxicillin. He was the only case that had a positive skin test to penicillin. Two other children presented with
reactions toward the end of their treatment course of amoxicillin, yet one patient developed immediate onset
allergy while the other patient developed non-immediate onset allergy after challenge.
Conclusions: This case series demonstrates diagnostic challenges facing physicians assessing allergic reactions to
amoxicillin. As onset of reactions can dictate severity and pathogenic type of allergy, a thorough clinical history and
subsequent appropriate diagnostic testing including medication challenge can help establish the diagnosis.
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Background
Amoxicillin is a commonly prescribed antibiotic for
treatment of community-acquired bacterial infections in
children [1]. Given that it is a first-line treatment for oti-
tis media and sinusitis, and given the high frequency of
viral-induced exanthemas including hives in this age
group [2, 3], it is not surprising that rashes developing
during the course of amoxicillin treatment are frequently
reported [1, 4]. Furthermore, up to 70 % of patients re-
ceiving amoxicillin during viral infections, particularly
Epstein–Barr virus, are reported to develop a self-
limiting maculopapular rash [5]. The estimated inci-
dence of allergy to amoxicillin ranges from 1 to 10 % [2,
4, 6]. However, many cases are diagnosed as allergic re-
actions without performing appropriate diagnostic tests
[1]. A detailed clinical history needs to account for viral
exanthemas in the differential diagnosis although the
distinction according to history is often challenging.
True allergic reactions to amoxicillin are mediated by
the immune system and are classified into immediate
(developing within 30 to 60 minutes of drug ingestion)
or non-immediate (beyond 1 hour of ingestion) type re-
actions [6, 7]. Immediate reactions may range in severity
from eruptions limited to the skin (hives/angioedema) to
reactions involving more than one organ system or
hypotension (that is, anaphylaxis) [7]. The risk of fatal
anaphylaxis with amoxicillin is not well documented, al-
though the risk with penicillin is estimated at 1 in 100,000
[1]. Non-immediate reactions occur more than 1 hour
after ingestion of antibiotic and usually last several days
[1]. For the most part, they are mild, self-resolving
maculopapular exanthemas or hives [1, 7]. Rarely,
non-immediate reactions may present with exfoliative
dermatitis, acute generalized exanthematous pustulosis
(AGEP), Stevens–Johnson syndrome (SJS), toxic epider-
mal necrolysis (TEN) and drug reaction with eosinophilia
and systemic symptoms (DRESS) [6, 8].
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Diagnostic confirmation is done by intradermal test-
ing, in vitro testing or oral challenges to the antibiotic in
question and the respective antibiotic family [4]. Drug
challenges are considered to be the gold standard in es-
tablishing a definitive diagnosis of an allergic reaction to
drugs [4, 6, 9]. In these cases, the challenge is begun
with one 100th to one tenth of the therapeutic dose and
if tolerated over 20 minutes, followed by a full dose with
an observation period of 1 hour [6]. Among diagnostic
procedures used to confirm the presence of amoxicillin
allergy, the oral challenge is considered to have the high-
est sensitivity although false negative cases and cases of
re-sensitization have been described; and 1 week chal-
lenges have been suggested to increase sensitivity [10, 11].
It is crucial to differentiate between immediate and
non-immediate reactions given their different pathogenic
mechanisms and management [6]. The immediate reac-
tions are considered to be immunoglobulin E (IgE)-me-
diated responses and non-immediate reactions are
thought to be T cell mediated [6, 7]. Unfortunately, the
pathogenesis of allergic reactions to antibiotics in gen-
eral and amoxicillin in particular is not well character-
ized; in addition to IgE and T cell-mediated mechanisms
it has been suggested that certain antibiotics can bind
non-covalently to antigen-interacting structures, such as
the T cell receptor or major histocompatibility complex,
and cause a direct stimulation of the immune response.
The term p-i concept (or pharmacological interaction
with immune receptors) has been coined for the latter
[12]. Antibiotics are small-sized molecules that are as-
sumed to be non-immunogenic, and hence numerous
hypotheses have been advanced to account for their abil-
ity to activate the immune system [13]. It has been sug-
gested that antibiotics have an ability to form conjugates
to larger carrier proteins in serum or intracellular space
(the hapten hypothesis) that are processed and eventu-
ally presented to T lymphocytes [6]. Others suggested
that certain antibiotics can bind non-covalently to
antigen-interacting structures such as the T cell receptor
or major histocompatibility complex, and cause a direct
stimulation of the immune response [13]. Given that
immediate reactions are considered IgE mediated and
may progress to a life-threatening reaction while most
non-immediate reactions are considered non-IgE medi-
ated and hence not life threatening, it is important to
make the distinction between these two reactions. All
immediate reactions should be treated by complete
avoidance and in the case of need, drug desensitization
[7, 14, 15]. However, studies suggest in the latter, future
use of the antibiotic is not an absolute contraindication
[16]. It is possible that in case 3 the immediate reaction
to challenge was not IgE mediated, but rather an acceler-
ated T cell-mediated reaction; however, the pathogenic
mechanisms could not be elucidated at this point and
hence strict avoidance was advised.
As the onset of non-immediate allergic reactions is
varied and the pathogenesis itself is poorly understood,
antibiotic reactions are difficult to diagnose even when a
detailed clinical history is evident. We present a case
series that describes three children who presented with
immediate and non-immediate reactions to amoxicillin
(Table 1). These cases demonstrate the challenges asso-
ciated with the diagnosis and management of amoxicillin-
related exanthemas.
Case presentation
Case 1 – Immediate reaction
A healthy 8-year-old white girl was receiving a standard
dose of oral amoxicillin for an uncomplicated pneumo-
nia. On the seventh day of treatment, 15 minutes follow-
ing her morning dose of amoxicillin, she developed
pruritic erythematous plaques that progressed all over
her body over the course of the day. There were no sys-
temic signs of anaphylaxis. Amoxicillin was discontinued
the same day. The rash resolved after 7 days. It is not
known whether this was her first exposure to amoxicil-
lin. She has avoided amoxicillin since then. An intrader-
mal test with Pre-Pen® (benzylpenicilloyl polylysine) was
negative. Three months later, she underwent an oral
challenge for amoxicillin at our allergy clinic. The oral
challenge was positive as she developed hives 20 minutes
following ingestion of the full dose (Fig. 1). No other
Table 1 Clinical characteristics and diagnostic test results of cases 1 to 3
Case Clinical history Oral challenge Skin test: Pre-Pen® (benzylpenicilloyl
polylysine)
1 8-year-old white girl Treated for uncomplicated pneumoniaa
Immediate reaction: seventh day of treatment, 15 minutes
after ingestion
Immediate reaction: 20 minutes
after ingestion of full dose
N/A
2 2-year-old white boy Treated for uncomplicated otitis mediaa
Non-immediate reaction: eighth day of treatment, rash noticed
in the morning after he woke up
Non-immediate reaction: 18 hours
post-ingestion of full dose
N/A
3 14-month-old Chinese boy Treated for otitis mediaa Non-immediate
reaction: third day of treatment, rash noticed after he awoke
from sleep, prior to morning dose
Immediate reaction: 15 minutes
post-ingestion of initial dose
Positive 8×16 mm (wheal/erythema)
aAll cases were being treated with amoxicillin, weight-based dose. N/A not applicable
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symptoms occurred and the hives resolved after a few
hours with no treatment. She was diagnosed with imme-
diate allergy to amoxicillin and advised to avoid amoxi-
cillin and all penicillin family antibiotics.
Case 2 – Non-immediate reaction
A healthy 2-year-old white boy was receiving a standard
dose of oral amoxicillin for an uncomplicated otitis
media. On the eighth day of treatment, he developed a
maculopapular rash (Fig. 2a) that coalesced to form large
raised plaques. The rash was noticed in the morning by
parents when he woke up. He was assessed in the emer-
gency room at the local children’s hospital and treated
symptomatically with Benadryl (diphenhydramine). His
rash lasted 3 to 4 days. He has not taken amoxicillin
since then. One month later, he presented at an allergy
clinic for an oral challenge to amoxicillin. He was given
one tenth of his weight-based dose, observed for 20 mi-
nutes and then received the full dose. He had no reactions
initially, but approximately 18 hours later he developed
non-pruritic erythematous plaques on his face, thighs and
arms (Fig. 2b). There were no systemic signs of anaphyl-
axis. He was given a diagnosis of non-immediate allergy to
amoxicillin and advised to avoid amoxicillin and all peni-
cillin family antibiotics.
Case 3 – Immediate and non-immediate reactions
A healthy 14-month-old Chinese boy presented with
hives on the third day of amoxicillin treatment for otitis
media shortly after he woke up from his sleep and prior
to his morning dose (Fig. 3a). There were no systemic
signs of anaphylaxis. His rash resolved after 2 to 3 days.
One month later, he presented at an allergy clinic for an
oral challenge to amoxicillin. The oral challenge was
positive because he developed hives 15 minutes (Fig. 3b)
Fig. 1 Hives developed on mid-back and right forearm 20 minutes
following ingestion of full dose of amoxicillin
Fig. 2 a. Erythematous maculopapular rash that coalesced to form
large raised plaques developed on day 8 of treatment with amoxicillin.
b. Erythematous plaques developed on his face, back, thighs and arms
18 hours following oral challenge to amoxicillin
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following ingestion of one tenth of his weight-based dose
of amoxicillin. An intradermal test with Pre-Pen® (ben-
zylpenicilloyl polylysine) was positive (Fig. 3c). He was
given a diagnosis of immediate allergy to amoxicillin and
advised to avoid amoxicillin and all penicillin family
antibiotics.
Discussion
This case series demonstrates the dilemma in diagnosing
immediate versus non-immediate onset allergy to amoxi-
cillin. Our cases demonstrate that children with immedi-
ate or non-immediate allergic reactions to amoxicillin
may have similar clinical histories. Thus drug challenges
may provide a relatively safe and efficient strategy to
establish diagnosis in these cases.
Allergic reactions are generally categorized as immediate
or non-immediate onset type, with the latter being more
frequent [2]. Ponvert et al. and Zambonino et al. reported
that 88 % and 92 % of healthy children were diagnosed with
non-immediate allergy following reaction to amoxicillin
while 12 % and 8 % were given a diagnosis of immediate al-
lergy to amoxicillin [17, 18]. The authors further demon-
strated that children with a likelihood of beta-lactam allergy
were more likely to experience early onset and greater se-
verity of disease [17]. Case 3 exemplifies the disparity be-
tween a clinical history suggesting a non-immediate onset
allergy to amoxicillin and the oral challenge and subsequent
intradermal testing establishing the presence of an immedi-
ate allergy. Cases 1 and 2 both reacted very late in the
course of their amoxicillin treatment (day 7 and 8 respect-
ively), yet case 1 developed immediate onset allergy and
case 2 developed non-immediate onset allergy. This dem-
onstrates the variability witnessed in allergic reactions to
amoxicillin and potential for diagnostic dilemma without
a thorough clinical history and subsequent challenge.
Of interest, no study has researched the likelihood of
presenting with non-immediate onset allergy and
subsequent positive diagnosis of immediate onset allergy
during drug provocation testing. Given that non-
immediate reactions are thought to be T cell-mediated re-
sponses [6, 7], there are two plausible explanations for the
immediate allergy during drug provocation testing in
case 3. It is possible that the patient’s immune system
developed an IgE-mediated response following the
previous non-immediate response. The more plausible
explanation could simply be that the parents have failed to
notice initial immediate symptoms related to amoxicillin
ingestion and hence reported a late occurring reaction.
Finally, our case series demonstrates the limited utility
of skin testing in the diagnosis of immediate and non-
immediate reactions. This is in keeping with other studies
suggesting that although many antibiotics are suspected
culprits of immediate reactions, skin tests are either
not validated, have a high false-negative rate or are
simply not available. For non-immediate reactions, skin
tests are even less useful given their high false-negative/
positive results [6, 13].
Conclusions
Although many infections are viral in nature, amoxicillin
is a commonly prescribed antibiotic that may trigger im-
mediate and non-immediate allergic reactions in the
pediatric age group [1, 4]. Diagnosis of drug allergy can
be challenging and an oral challenge may be crucial in
establishing the diagnosis. Future studies assessing the
sensitivity and specificity of new diagnostic strategies to
establish the presence of immediate or non-immediate
reactions are required to better manage these patients.
Consent
Written informed consent was obtained from the patients’
legal guardians for publication of this case report and any
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Fig. 3 a. Hives developed throughout his body on day 3 of treatment with amoxicillin. b. Hives developed 15 minutes following ingestion of
one tenth of weight-based dose of amoxicillin. c. Results of intradermal testing showing wheal size of 8×16 mm (wheal/erythema)
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